226 related articles for article (PubMed ID: 18241248)
1. Challenging the maximum flow rate: a new index of voiding dysfunction in men with benign prostatic enlargement.
Valentini FA; Nelson PP; Besson GR; Zimmern PE
BJU Int; 2008 Apr; 101(8):995-9. PubMed ID: 18241248
[TBL] [Abstract][Full Text] [Related]
2. Modelized analysis of pressure-flow studies of patients with lower urinary tract symptoms due to benign prostatic enlargement.
Valentini FA; Zimmern PE; Besson GR; Nelson PP
Neurourol Urodyn; 2003; 22(1):45-53. PubMed ID: 12478601
[TBL] [Abstract][Full Text] [Related]
3. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
van Venrooij GE; van Melick HH; Eckhardt MD; Boon TA
Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189
[TBL] [Abstract][Full Text] [Related]
5. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
J Urol; 2009 Dec; 182(6):2831-5. PubMed ID: 19837428
[TBL] [Abstract][Full Text] [Related]
7. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
[TBL] [Abstract][Full Text] [Related]
8. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of detrusor activity during micturition in patients with benign prostatic enlargement with a clinical nomogram.
Rosier PF; de Wildt MJ; Debruyne FM; Wijkstra H; de la Rosette JJ
J Urol; 1996 Aug; 156(2 Pt 1):473-8; discussion 478-9. PubMed ID: 8683707
[TBL] [Abstract][Full Text] [Related]
10. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Van Venrooij GE; Eckhardt MD; Boon TA
Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
[TBL] [Abstract][Full Text] [Related]
11. Categorization of obstruction using noninvasive pressure flow measurements: sensitivity to change following prostatectomy.
Sajeel M; Harding C; Robson W; Drinnan M; Griffiths C; Pickard R
J Urol; 2007 Sep; 178(3 Pt 1):996-1000; discussion 1000-1. PubMed ID: 17632154
[TBL] [Abstract][Full Text] [Related]
12. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
Güler C; Tüzel E; Doğantekin E; Kiziltepe G
Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
[TBL] [Abstract][Full Text] [Related]
13. Chronic prostatitis presenting with dysfunctional voiding and effects of pelvic floor biofeedback treatment.
He W; Chen M; Zu X; Li Y; Ning K; Qi L
BJU Int; 2010 Apr; 105(7):975-7. PubMed ID: 19751259
[TBL] [Abstract][Full Text] [Related]
14. [Quantification of bladder-outlet obstruction in males: standard method vc VBN method].
Valentini FA; Griffiths DJ; Zimmern PE; Besson GR; Nelson PP
Ann Readapt Med Phys; 2005 Feb; 48(1):11-9. PubMed ID: 15664679
[TBL] [Abstract][Full Text] [Related]
15. Effects of retrospective quality control on pressure-flow data with computer-based urodynamic systems from men with benign prostatic hyperplasia.
Liao LM; Schaefer W
Asian J Androl; 2007 Nov; 9(6):771-80. PubMed ID: 17968462
[TBL] [Abstract][Full Text] [Related]
16. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
Zhang P; Wu Z; Gao J
Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
[TBL] [Abstract][Full Text] [Related]
17. Is it possible to predict post-residual voided urine by bladder scan before uroflowmetry--a useful and timesaving test to reduce the number of non--evaluable uroflow measurements?
Dicuio M; Vesely S; Knutson T; Damber JE; Cuzzocrea DE; Dahlstrand C
Arch Ital Urol Androl; 2010 Jun; 82(2):100-4. PubMed ID: 20812533
[TBL] [Abstract][Full Text] [Related]
18. [Surgery (TUR-P) as a recommended initial treatment modality for the presented case].
Gotoh M
Hinyokika Kiyo; 2005 Sep; 51(9):603-8. PubMed ID: 16229373
[TBL] [Abstract][Full Text] [Related]
19. [Effects of transurethral catheterization on uroflow rate in the pressure-flow study of patients with benign prostatic hyperplasia].
Zhao SC; Zheng SB; Tan WL; Mao XM; Zhang P; Huang ZM; Zhang HJ; Zuo Y
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):710-2. PubMed ID: 17918710
[TBL] [Abstract][Full Text] [Related]
20. Variability of pressure-flow analysis parameters in repeated cystometry in patients with benign prostatic hyperplasia.
Rosier PF; de la Rosette JJ; Koldewijn EL; Debruyne FM; Wijkstra H
J Urol; 1995 May; 153(5):1520-5. PubMed ID: 7536260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
